ATLANTA, GA--(Marketwire - April 17, 2008) - AtheroGenics, Inc. (NASDAQ: AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today announced that it will release its first quarter 2008 financial results on Thursday, April 24, 2008 before the U.S. financial markets open.
